Renal Solutions Receives FDA Clearance
June 23, 2005
Renal Solutions has received clearance from the US Food & Drug Administration (FDA) to begin commercialization of the Allient® Sorbent Hemodialysis System in chronic and acute hemodialysis applications. The company also received approval of an Investigational Device Exemption (IDE) for the initiation of a home hemodialysis clinical trial. Pete DeComo, CEO, expressed his pleasure with the "broad label indication for use in chronic and acute hemodialysis as prescribed by a physician." For more information, read the full release.
« Haley Systems Introduces OEM Program | | Ron Taylor Joins Aethon Board »
